Compare Dr. Reddy's Laboratories Ltd Common Stock (RDY) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dr. Reddy's Laboratories Ltd Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 6× Vir Biotechnology Inc. Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| RDY | VIR | |
|---|---|---|
Market Cap | $10.78B | $1.80B |
Volume | 2,724,343 | 1,782,836 |
Sector | Health | Health |
52-Week High | $15.38 | $11.78 |
52-Week Low | $11.38 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.68B | $1.36B |
Dividend Yield | 0.65% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
